Trial
NCT04726592
Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Emergency Room
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
—
Condition
Migraine
Intervention
Clorazepate Dipotassium
Why stopped
It has been determined that continuing with enrollments in this study is no longer justified due to the lack of significant impact on the expected outcomes.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-09-08